上海博研生物工程研究中心為您現(xiàn)貨提供*的產品與服務，本中心產品齊全，保證實驗的有效性，提供，是您科研實驗產品的一站式平臺，咨詢。！

產品名稱：Anti-HPV16-E7抗體,人類乳頭狀瘤病毒16-E7抗體價格
中文名稱：人類乳頭狀瘤病毒16-E7抗體
英文名稱：Anti-HPV16-E7
產品編號：BYK-0992R
產品別名：E7; Human Papilloma Virus; Human papillomavirus type 16 E7; Human papillomavirus type 16 E7; Protein E7; Human Papillomavirus 16 （E7）; HPV16 E7; E7 protein （HPV16）; VE7_HPV16.

本公司另供應“人類乳頭狀瘤病毒16-E7抗體”的標記有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
產品規(guī)格：100ug/200ug
產品濃度： 1mg/1ml
抗體來源：兔源、鼠源、山羊
克 隆：單克隆抗體、多克隆抗體
抗體類型：一抗
性 狀： 凍干粉或液體
保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-HPV16-E7抗體,人類乳頭狀瘤病毒16-E7抗體價格技術說明，產品*，由于篇幅原因，更多信息請：

Anti-Phospho-HP1（pTyr43）（Phospho-heterochromatin protein 1）（fruit fly）  抗異染色質蛋白1磷酸化抗體（果蠅）
Anti-HPV （Human papillomavirus）  人類乳頭狀瘤病毒抗體
Anti-HPV16-E6/E6 protein（Human papillomavirus type 16）  人類乳頭狀瘤病毒16抗體
Anti-HPV18-E6/E6 protein（Human papillomavirus type 18）  人類乳頭狀瘤病毒18抗體
Anti-HPV16-E7/E7 protein（Human papillomavirus type 16）  人類乳頭狀瘤病毒16-E7抗體
Anti-HPV16/18 protein（Human papillomavirus type 16/18）  人類乳頭狀瘤病毒16/18抗體
Anti-Hpt/HP（haptoglobin）  結合珠蛋白/觸珠蛋白抗體
Anti-H-ras  原癌基因H-ras抗體
Anti-HRG-alpha （Heregulin-alpha）  抗HRGα抗體
Anti-HSA（Human sermu albumin）  兔抗人血清白蛋白抗體
Anti-HSA/human Serum albumin Monoclonal Antibody  鼠抗人血清白蛋白單克隆抗體
Anti-NRG1/HRG-β（Heregulin-β）  抗HRGβ抗體
Anti-HSTF2/HSF2（Heat Shock Transcription Factor 2）  熱休克轉錄因子2抗體
Anti-phospho-HP1（pTyr）（phospho-heterochromatin protein 1）（fruit fly）  抗異染色質蛋白1磷酸化抗體（果蠅）
Anti-HOXA10 （homeobox protein A10）  HOXA10抗體

產品介紹：

Human papilloma viruses （HPVs） can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximay 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.